Mphasis Approves Revision in Stock Options and RSU Grants
Mphasis Ltd · Others (Uncategorized) · 08 Sept 2026, 2:31 am
Mphasis Approves Revision in Stock Options and RSU Grants Mphasis Limited cancelled its prior grant of 4,15,060 ESOPs and 92,400 RSUs approved on 20th Aug'26. On 7th Sep'26, the ESOP Compensation Committee approved fresh grants comprising 1,01,030 Options under ESOP 2016 at an exercise price of ₹2,371 per share with a 5-year vesting schedule and a 60-month exercise window post-vesting. Additionally, 22,510 RSUs were granted under RSU Plan 2021 at an exercise price of ₹10 each, vesting equally over 4 years. Each unit converts into one equity share of ₹10 face value.
Original exchange filing (PDF)
More announcements from Mphasis Ltd
- Transcript of the Investors/Analysts call · 09 Nov 2026
- Exercise of 15500 Employees Stock Options and 137391 Restricted Stock Units · 09 Nov 2026
- Audio Recording of the Investors/Analysts call · 06 Nov 2026
- Intimation under Regulation 8 of the SEBI (Prohibition of Insider Trading) Regulations, 2015 · 06 Nov 2026
- Intimation under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 06 Nov 2026
- Presentation of Investors/Analysts call · 06 Nov 2026
- Outcome of Board Meeting · 06 Nov 2026
- Outcome of the Board Meeting · 06 Nov 2026
